Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
20/07/2022 14:54
July 20 (Reuters) - Guided Therapeutics Inc GTHP.PK :
* GUIDED THERAPEUTICS RECEIVES INSTITUTIONAL REVIEW BOARD
APPROVAL
TO START CLINICAL STUDY FOR FDA APPROVAL OF THE LUVIVA® ADVANCED
CERVICAL SCAN
Source text for Eikon: ID:nBw11dGtda
Further company coverage: GTHP.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guided Therapeutics
See all newsBrief: Guided Therapeutics Receives $700,000 Purchase Order And Initial Payment From New Chinese Distributor
Brief: Guided Therapeutics Signs Agreement To Begin Clinical Trial For Us FDA Approval
Brief: Guided Receives IRB Approval To Start Clinical Study For FDA Approval Of Luviva Advanced Cervical Scan
Brief: Guided Therapeutics Inc Have Applied To List Common Stock On Nasdaq Capital Market
Brief: Guided Therapeutics Says Replaces Convertible Note Facility And Significantly Reduces Dilution